Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 2004
Molecular and pharmacological characterization of the monkey histamine H(3) receptor
B B Yao, R Sharma, S Cassar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1997
Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin
D G Witte, M E Brune, S P Katwala, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien
W A Carroll, K B Sippy, T A Esbenshade, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist
M D Meyer, R J Altenbach, A A Hancock, et al.
European Journal of Pharmacology
|
May 26, 1997
[3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin
L M Ireland, J C Cain, G Rotert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype
S M Knepper, S A Buckner, M E Brune, et al.
Pharmacology
|
February 19, 1998
Cardiovascular activity of A-74283, a 5-hydroxytryptamine 1A agent, in the spontaneously hypertensive rat
J Y Lee, A A Hancock, R B Warner, et al.
Journal of Medicinal Chemistry
|
June 1, 1987
Conformationally defined adrenergic agents. 5. Resolution, absolute configuration, and pharmacological characterization of the enantiomers of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline: a potent agonist at alpha-adrenoceptors
J F DeBernardis, D J Kerkman, D L Arendsen, et al.
Pharmacology
|
December 1, 1996
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs
M E Brune, S P Katwala, I Milicic, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
Pharmacological classification of histamine H3 receptor agents across species is attributable to transmembrane 3 sequence differences
T A Esbenshade, B R Estvander, T R Miller, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 2004
Molecular and pharmacological characterization of the monkey histamine H(3) receptor
B B Yao, R Sharma, S Cassar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1997
Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin
D G Witte, M E Brune, S P Katwala, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien
W A Carroll, K B Sippy, T A Esbenshade, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist
M D Meyer, R J Altenbach, A A Hancock, et al.
European Journal of Pharmacology
|
May 26, 1997
[3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin
L M Ireland, J C Cain, G Rotert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype
S M Knepper, S A Buckner, M E Brune, et al.
Pharmacology
|
February 19, 1998
Cardiovascular activity of A-74283, a 5-hydroxytryptamine 1A agent, in the spontaneously hypertensive rat
J Y Lee, A A Hancock, R B Warner, et al.
Journal of Medicinal Chemistry
|
June 1, 1987
Conformationally defined adrenergic agents. 5. Resolution, absolute configuration, and pharmacological characterization of the enantiomers of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline: a potent agonist at alpha-adrenoceptors
J F DeBernardis, D J Kerkman, D L Arendsen, et al.
Pharmacology
|
December 1, 1996
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs
M E Brune, S P Katwala, I Milicic, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
Pharmacological classification of histamine H3 receptor agents across species is attributable to transmembrane 3 sequence differences
T A Esbenshade, B R Estvander, T R Miller, et al.
Page
of 6